Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK

Journal of Cellular Biochemistry

Volumn 98, Issue 4, 2006, Pages 789-797

  Huang, Huei Mei ^a   Chiou, Huei Yu ^a   Chang, Ju Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Activin A; ERK; Globin gene; GM CSF; IL 3; p38 MAPK; SCF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVIN A; ALPHA GLOBIN; CYTOKINE; GLOBIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; METHYLCELLULOSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ZETA GLOBIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN K 562; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION;

ACTIVINS; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; ENZYME INHIBITORS; ERYTHROID PROGENITOR CELLS; GENE EXPRESSION REGULATION; HUMANS; INHIBIN-BETA SUBUNITS; K562 CELLS; MAP KINASE SIGNALING SYSTEM; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 33745608475     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20713     Document Type: Article

References (37)

1. Beattie GM, Lopez AD, Bucay N, Hinton A, Firpo MT, King CC, Hayek A. 2005. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23:489-495.
2. Broxmeyer HE, Hangoc G, Zucali JR, Mason A, Schwall R, Carow C, Cooper S. 1991. Effects in vivo of purified recombinant human activin and erythropoietin in mice. Int J Hematol 54:447-454.
3. Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.
4. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY. 2002. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med 227:75-87.
5. Cocolakis E, Lemay S, Ali S, Lebrun JJ. 2001. The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem 276:18430-18436.
6. Efimova T, Broome AM, Eckert RL. 2003. A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation. J Biol Chem 278:34277-34285.
7. Eto Y, Tsuji T, Takezawa M, Takano S, Yokogawa Y, Shibai H. 1987. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochem Biophys Res Commun 142:1095-1103.
8. Frigon NL Jr, Shao L, Young AL, Maderazo L, Yu J. 1992. Regulation of globin gene expression in human K562 cells by recombinant activin A. Blood 79:765-772.
9. Hilden K, Tuuri T, Eramaa M, Ritvos O. 1994. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Blood 83:2163-2170.
10. Hilden K, Tuuri T, Eramaa M, Ritvos O. 1999. Co-ordinate expression of activin A and its type I receptor mRNAs during phorbol ester-induced differentiation of human K562 erythroleukemia cells. Mol Cell Endocrinol 153:137-145.
11. Huang HM, Chang TW, Liu JC. 2004. Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase. Biochem Biophys Res Commun 320:1247-1252.
12. James D, Levine AJ, Besser D, Hemmati-Brivanlou A. 2005. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132:1273-1282.
13. Kang CD, Do IR, Kim KW, Ahn BK, Kim SH, Chung BS, Jhun BH, Yoo MA. 1999. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells. Exp Mol Med 31:76-82.
14. Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M. 2004. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells. J Cell Physiol 198:370-376.
15. Komatsu K, Nakamura H, Masaoka T, Akedo H. 1995. Synergistic effects of basic fibroblast growth factor and hematopoietic growth factors on colony formation of K562 human leukemic cells. Leukemia 9:1565-1568.
16. Leary JF, Ohlsson-Wilhelm BM, Giuliano R, LaBella S, Farley B, Rowley PT. 1987. Multipotent human hematopoietic cell line K562: Lineage-specific constitutive and inducible antigens. Leuk Res 11:807-815.
17. Leppa S, Pirkkala L, Saarento H, Sarge KD, Sistonen L. 1997. Overexpression of HSF2-beta inhibits hemin-induced heat shock gene expression and erythroid differentiation in K562 cells. J Biol Chem 272:15293-15298.
18. Liu JJ, Hou SC, Shen CK. 2003. Erythroid gene suppression by NF-kappa B. J Biol Chem 278:19534-19540.
19. Lotem J, Sachs L. 2002. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene 21:3284-3294.
20. Luisi S, Florio P, Reis FM, Petraglia F. 2001. Expression and secretion of activin A: Possible physiological and clinical implications. Eur J Endocrinol 145:225-236.
21. Maguer-Satta V, Bartholin L, Jeanpierre S, Ffrench M, Martel S, Magaud JP, Rimokh R. 2003. Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family. Exp Cell Res 282:110-120.
22. McGuckin CP, Liu WM, Gordon-Smith EC, Uhr MR. 1996. A novel approach to investigating the erythroid lineage, using both receptor analysis and haemoglobin detection. Br J Haematol 95:457-460.
23. McNiece I, Andrews R, Stewart M, Clark S, Boone T, Quesenberry P. 1989. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: Synergistic interaction of GM-CSF plus G-CSF. Blood 74:110-114.
24. Migliaccio G, Migliaccio AR, Druzin ML, Giardina PJ, Zsebo KM, Adamson JW. 1992. Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. Blood 79:2620-2627.
25. Mizuguchi T, Kosaka M, Saito S. 1993. Activin A suppresses proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood. Blood 81:2891-2897.
26. Nagata Y, Todokoro K. 1999. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94:853-863.
27. Nagata Y, Takahashi N, Davis RJ, Todokoro K. 1998. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92:1859-1869.
28. Ono K, Han J. 2000. The p38 signal transduction pathway. Activation and function. Cell Signal 12:1-13.
29. Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouyssegur J. 1993. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90:8319-8323.
30. Park JI, Choi HS, Jeong JS, Han JY, Kim IH. 2001. Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ 12:481-486.
31. Schwall R, Schmelzer CH, Matsuyama E, Mason AJ. 1989. Multiple actions of recombinant activin-A in vivo. Endocrinology 125:1420-1423.
32. Shav-Tal Y, Zipori D. 2002. The role of activin a in regulation of hemopoiesis. Stem Cells 20:493-500.
33. Shiozaki M, Sakai R, Tabuchi M, Eto Y, Kosaka M, Shibai H. 1989. In vivo treatment with erythroid differentiation factor (EDF/activin A) increases erythroid precursors (CFU-E and BFU-E) in mice. Biochem Biophys Res Commun 165:1155-1161.
34. Shiozaki M, Sakai R, Tabuchi M, Nakamura T, Sugino K, Sugino H, Eto Y. 1992. Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis. Proc Natl Acad Sci USA 89:1553-1556.
35. Witt O, Monkemeyer S, Ronndahl G, Erdlenbruch B, Reinhardt D, Kanbach K, Pekrun A. 2003. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 101:2001-2007.
36. Yu J, Dolter KE. 1997. Production of activin A and its roles in inflammation and hematopoiesis. Cytokines Cell Mol Ther 3:169-177.
37. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ. 1997. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 94:4698-4703.